Predictive Oncology Inc
POAI5.950USD
0.0000.00%
종가 02/09, 16:00（ET）시세는 15분 지연됩니다
4.56M시가총액
손실P/E TTM
자세한 내용은 Predictive Oncology Inc 회사
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Predictive Oncology Inc 정보
종목 코드 POAI
회사 이름Predictive Oncology Inc
상장일Dec 18, 2009
CEOVennare (Raymond F)
직원 수23
유형Ordinary Share
회계 연도 종료Dec 18
주소91 43Rd Street
도시PITTSBURGH
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호15201
전화14124321500
웹사이트https://predictive-oncology.com/
종목 코드 POAI
상장일Dec 18, 2009
CEOVennare (Raymond F)
Predictive Oncology Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Joshua Blacher
Mr. Joshua Blacher
Interim Chief Financial Officer
Interim Chief Financial Officer
6.47K
--
Mr. Raymond F. Vennare
Mr. Raymond F. Vennare
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.43K
-2373.00%
Dr. Daniel E. (Dan) Handley, Ph.D.
Dr. Daniel E. (Dan) Handley, Ph.D.
Independent Director
Independent Director
5.45K
--
Dr. Veena Rao, Ph.D.
Dr. Veena Rao, Ph.D.
Independent Director
Independent Director
4.92K
--
Mr. Chuck (Charles) Nuzum, Sr.
Mr. Chuck (Charles) Nuzum, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mr. Gregory S. St. Clair, Sr.
Mr. Gregory S. St. Clair, Sr.
Independent Director
Independent Director
--
--
Dr. Matthew J. Hawryluk, Ph.D.
Dr. Matthew J. Hawryluk, Ph.D.
Independent Director
Independent Director
--
--
Mr. Shawn P. Matthews
Mr. Shawn P. Matthews
Director
Director
--
--
Mr. Thomas McLaughlin
Mr. Thomas McLaughlin
Chief Investment Officer
Chief Investment Officer
--
--
Ms. Sara Turken
Ms. Sara Turken
General Counsel
General Counsel
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Joshua Blacher
Mr. Joshua Blacher
Interim Chief Financial Officer
Interim Chief Financial Officer
6.47K
--
Mr. Raymond F. Vennare
Mr. Raymond F. Vennare
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.43K
-2373.00%
Dr. Daniel E. (Dan) Handley, Ph.D.
Dr. Daniel E. (Dan) Handley, Ph.D.
Independent Director
Independent Director
5.45K
--
Dr. Veena Rao, Ph.D.
Dr. Veena Rao, Ph.D.
Independent Director
Independent Director
4.92K
--
Mr. Chuck (Charles) Nuzum, Sr.
Mr. Chuck (Charles) Nuzum, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mr. Gregory S. St. Clair, Sr.
Mr. Gregory S. St. Clair, Sr.
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: 7 hours ago
마지막 업데이트: 7 hours ago
주주
주주 유형
주주
주주
비율
Luo (Weiyu)
2.89%
SLN Capital Ltd
1.73%
Diametric Capital
0.15%
The Vanguard Group, Inc.
0.12%
Blacher (Joshua)
0.04%
기타
95.07%
주주
주주
비율
Luo (Weiyu)
2.89%
SLN Capital Ltd
1.73%
Diametric Capital
0.15%
The Vanguard Group, Inc.
0.12%
Blacher (Joshua)
0.04%
기타
95.07%
주주 유형
주주
비율
Individual Investor
3.19%
Corporation
1.73%
Investment Advisor/Hedge Fund
0.15%
Investment Advisor
0.14%
기타
94.79%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
37
43.21K
0.29%
+14.59K
2025Q3
37
7.39K
0.21%
-26.00K
2025Q2
44
299.51K
2.93%
-288.64K
2025Q1
50
299.35K
3.35%
-293.31K
2024Q4
56
353.94K
4.97%
-213.96K
2024Q3
54
322.08K
5.97%
-246.26K
2024Q2
57
408.73K
8.00%
-114.07K
2024Q1
66
484.20K
11.91%
-86.59K
2023Q4
66
502.45K
12.36%
-67.11K
2023Q3
69
499.46K
12.41%
-50.95K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Luo (Weiyu)
430.05K
2.89%
+430.05K
--
Oct 24, 2025
SLN Capital Ltd
258.03K
1.73%
+258.03K
--
Oct 24, 2025
Diametric Capital
21.81K
0.15%
+21.81K
--
Sep 30, 2025
Blacher (Joshua)
6.47K
0.04%
--
--
Oct 24, 2025
Vennare (Raymond F)
6.43K
0.04%
-2.37K
-26.95%
Nov 28, 2025
Nuzum (Charles Lee Sr)
6.31K
0.04%
--
--
Oct 24, 2025
St Clair (Gregory Sr)
5.73K
0.04%
+1.00
+0.02%
Oct 24, 2025
Chung-Welch (Nancy)
5.60K
0.04%
+4.31K
+334.78%
Sep 09, 2025
Handley (Daniel E)
5.45K
0.04%
--
--
Oct 24, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Sep 25, 2025
Merger
15→1
Apr 20, 2023
Merger
20→1
Apr 20, 2023
Merger
20→1
Apr 20, 2023
Merger
20→1
Apr 20, 2023
Merger
20→1
날짜
배당락일
유형
비율
Sep 25, 2025
Merger
15→1
Apr 20, 2023
Merger
20→1
Apr 20, 2023
Merger
20→1
Apr 20, 2023
Merger
20→1
Apr 20, 2023
Merger
20→1
